Browse by Poster Title

• F
• P-293
  Factors Associated with Different Dosage Forms of Disease-modifying Agents in Older Adults with Multiple Sclerosis
  Favorite
• P-515
  Factors Predictive of Treatment Success of Novel Disease-modifying Anti-rheumatic Drugs (DMARDS) in Patients with Inflammatory Arthritis
  Favorite
• P-477
  Feasibility and Acceptability of the Optimeds Tool for Multidisciplinary Medication Review in Belgian Nursing Homes
  Favorite
• P-536
  Flares After Hydroxychloroquine Reduction or Discontinuation in a Multinational Inception Cohort of Systemic Lupus
  Favorite
• P-027
  Four Competing Definitions of Morphine Equivalence Insidiously Inhibit Evidence Synthesis
  Favorite
• P-095
  Fracture Outcome Coding in Observational Osteoporosis Drug Effects Studies: A Scoping Review
  Favorite
• P-382
  Fracture Risk Following the Initiation Of antihypertensive Therapy Amongst Frail Elderly People: A Self-controlled Case Series analysis
  Favorite
• P-574
  Frequency, Characteristics, and Subsequent Treatment (Tx) of Real-world Patients (pts) Who Discontinue Hedgehog Inhibitors (HHIs) as First-line (1L) Systemic Tx for Advanced Basal Cell Carcinoma (aBCC)
  Favorite
• P-480
  From Contact Coverage to Effective Coverage of Community Care for Patients with Severe Mental Disorders: A Real-world Investigation from Italy
  Favorite